REQUEST A DEMO
Total
USD $0.00
« Back to previous page

India Pharma and Healthcare Sector Report Half-Annual Update - October 2021

An EMIS Insights Industry Report
EMIS is an ISI Emerging Markets Group Company
Date: October 2021
Pages: 9
Available in: English

India’s pharmaceuticals and healthcare sector has been dominated by a second wave of COVID-19 infections beginning in April 2021 driven by the Delta variant. The surge caught the Indian government and the pharmaceuticals and healthcare sector unprepared, pushing the healthcare system to breaking point.​ By July 2021, the deadly wave of infections had subsided as Indian citizens showed increasing signs of natural immunity to the SARS-CoV-2 virus and its variants, thanks to natural infection and increasing vaccination coverage. Nevertheless, vaccination coverage remains low in India, with only approximately 20% of the population fully vaccinated by mid-October 2021 due to the immense logistical challenges involved in vaccinating a country with a 1.4 billion-strong population. 

India Pharma and Healthcare Sector Report Half-Annual Update - October 2021 - Page 1
Buy full report USD 95.00 Payment methods include:

DOWNLOAD A SAMPLE
Have a question?

Email us at: customerenquiries@emis.com

SEE BELOW FOR A COMPLETE TABLE OF REPORT CONTENTS:

India Pharma and Healthcare Sector Report Half-Annual Update - October 2021 -  Page 2
India Pharma and Healthcare Sector Report Half-Annual Update - October 2021 -  Page 3
ONCE YOU HAVE COMPLETED YOUR PURCHASE,
YOU WILL BE ABLE TO DOWNLOAD THIS REPORT IMMEDIATELY AS A PDF
If you have any questions, please contact customerenquires@emis.com
Buy full report
Need ongoing access to company, industry or country information?